A "cloud of uncertainty" strained IronNet's cash flows and negatively affected liquidity to the point where the cybersecurity vendor had to begin winding
China’s Most Indebted Property Developer, China Evergrande Group EGRNF, has Filed For Chapter 15 Bankruptcy Protection In A U.S. Court. According to Reuters,…
NephroGenex Inc (NASDAQ: NRX), the pharma company focused on the development of therapeutics to treat kidney disease, is soaring by 68.05 percent to $2.42 on Monday. The astronomical move follows the company s announcement of FDA clearance for IND Application for clinical study of Intravenous. Read More. Don t Miss Any Updates! News Directly in Your Inbox Subscribe to: